As ErbB2 overexpression in most breast cancer patients represents increased transcription from an amplified ErbB2 gene locus (82), the oncogenic drive is likely to depend on efficient processing of the mRNA for the driver oncogene ErbB2. The gene discussed is ERBB2; the disease is breast carcinoma.